Opinion

Video

Recent Data from INTERCEPT and COSMOS-CRC-01 in Colorectal Cancer

Author(s):

John L. Marshall, MD,Benjamin Weinberg, MD

The panel reviews recent data on MRD testing in colorectal cancer, highlighting the INTERCEPT and COSMOS-CRC-01 studies.

Related Videos
Neil Iyengar, MD, and Chandler Park, MD, FACP
Stephen V. Liu, MD
Related Content
OncLive's OncFive: The Top 5 Oncology Articles of the Week
December 21st 2024

The OncFive: Top Oncology Articles for the Week of 12/15

Mazyar Shadman, MD, MPH, associate professor, Clinical Research Division, medical director, Cellular Immunotherapy, Fred Hutchinson Cancer Center
December 19th 2024

Zanubrutinib Leads the Way for Advancements in CLL Management: With Mazyar Shadman, MD, MPH

Cathy Eng, MD, FACP, FASCO
December 6th 2024

NGS and ctDNA Testing Guide Treatment Selection and Sequencing in mCRC

Delve into Recent NCCN Guideline Updates for Hepatobiliary and CRC Management: With Alan P. Venook, MD
October 24th 2024

Delve into Recent NCCN Guideline Updates for Hepatobiliary and CRC Management: With Alan P. Venook, MD

Alan P. Venook, MD, of UCSF
November 27th 2024

Targeted Therapies Represent Core 2024 NCCN GI Cancer Guideline Advancements

The Microbiome and Colon Cancer | Image Credit: © Anatomy Insider - stock.adobe.com
November 25th 2024

The Microbiome and Colon Cancer: Dietary Influence on Incidence, Morbidity, and Mortality